AU2001289861A1 - Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications - Google Patents
Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applicationsInfo
- Publication number
- AU2001289861A1 AU2001289861A1 AU2001289861A AU8986101A AU2001289861A1 AU 2001289861 A1 AU2001289861 A1 AU 2001289861A1 AU 2001289861 A AU2001289861 A AU 2001289861A AU 8986101 A AU8986101 A AU 8986101A AU 2001289861 A1 AU2001289861 A1 AU 2001289861A1
- Authority
- AU
- Australia
- Prior art keywords
- polymorphisms
- diagnostic
- therapeutic applications
- human genes
- regulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 102000054765 polymorphisms of proteins Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6497—Endothelin-converting enzyme (3.4.24.71)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24071—Endothelin-converting enzyme 1 (3.4.24.71)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00120123.5 | 2000-09-19 | ||
| EP00120123 | 2000-09-19 | ||
| PCT/EP2001/010087 WO2002024747A2 (en) | 2000-09-19 | 2001-08-31 | Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001289861A1 true AU2001289861A1 (en) | 2002-04-02 |
Family
ID=8169848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001289861A Abandoned AU2001289861A1 (en) | 2000-09-19 | 2001-08-31 | Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001289861A1 (en) |
| WO (1) | WO2002024747A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2405023B1 (en) * | 2003-11-26 | 2014-01-08 | Celera Corporation | Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof |
| JP5129563B2 (en) * | 2004-03-18 | 2013-01-30 | ラスク・インテレクチュアル・リザーブ・アクチェンゲゼルシャフト | Method for diagnosing or predicting susceptibility to optic neuropathy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718487D0 (en) * | 1997-09-02 | 1997-11-05 | Univ Sheffield | Pulmonary hypertension |
-
2001
- 2001-08-31 AU AU2001289861A patent/AU2001289861A1/en not_active Abandoned
- 2001-08-31 WO PCT/EP2001/010087 patent/WO2002024747A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002024747A3 (en) | 2003-07-31 |
| WO2002024747A2 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163278A (en) | Formulations comprising glp-1 molecules and use thereof in the preparation of medicaments | |
| IL162678A0 (en) | N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases | |
| AU7067200A (en) | Skin care compositions and treatments | |
| AU2002258728A1 (en) | Gene brcc-3 and diagnostic and therapeutic uses thereof | |
| AU2002305151A1 (en) | Gene scc-112 and diagnostic and therapeutic uses thereof | |
| AU2002303261A8 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
| AU2003265620A1 (en) | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition | |
| AU1164601A (en) | Therapeutic use and formulation | |
| AU2002252976A1 (en) | Hydrazones and their therapeutic use | |
| HUP0201997A3 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
| AU4104200A (en) | Cdna molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy | |
| AU2002323286A1 (en) | Human toxicologically relevant genes and arrays | |
| AU2001289861A1 (en) | Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications | |
| AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
| AU2003245858A1 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
| AU2002303262A1 (en) | Gene shinc-1 and diagnostic and therapeutic uses thereof | |
| AU2003264094A1 (en) | Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications | |
| AU2003240253A1 (en) | Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications | |
| AU2003244498A1 (en) | Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications | |
| AU2001287269A1 (en) | Human genes and expression products | |
| AU2003270350A1 (en) | Isoxazoles and their use in the treatment of ischemic diseases | |
| AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
| AU2003280867A1 (en) | Specific haplotypes of the mdr1 gene and their use in diagnosis and therapy | |
| AU2003208289A1 (en) | Deuterated spirocyclopentanimidazolinones and the use thereof in the treatment of cardiovascular diseases | |
| AU2003235665A1 (en) | Diagnostic and therapeutic uses of topors |